JP2010516432A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010516432A5 JP2010516432A5 JP2009548356A JP2009548356A JP2010516432A5 JP 2010516432 A5 JP2010516432 A5 JP 2010516432A5 JP 2009548356 A JP2009548356 A JP 2009548356A JP 2009548356 A JP2009548356 A JP 2009548356A JP 2010516432 A5 JP2010516432 A5 JP 2010516432A5
- Authority
- JP
- Japan
- Prior art keywords
- medical device
- uneven surface
- stent
- group
- bioactive agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012867 bioactive agent Substances 0.000 claims 8
- 230000002792 vascular Effects 0.000 claims 7
- 239000011248 coating agent Substances 0.000 claims 6
- 238000000576 coating method Methods 0.000 claims 6
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 claims 6
- 229960002930 sirolimus Drugs 0.000 claims 6
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 claims 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 4
- HKVAMNSJSFKALM-GKUWKFKPSA-N Everolimus Chemical compound C1C[C@@H](OCCO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 HKVAMNSJSFKALM-GKUWKFKPSA-N 0.000 claims 4
- 238000005530 etching Methods 0.000 claims 4
- 229960005167 everolimus Drugs 0.000 claims 4
- 239000003112 inhibitor Substances 0.000 claims 4
- -1 polytetrafluoroethylene Polymers 0.000 claims 4
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 claims 3
- CBPNZQVSJQDFBE-FUXHJELOSA-N Temsirolimus Chemical compound C1C[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 CBPNZQVSJQDFBE-FUXHJELOSA-N 0.000 claims 3
- 229920000249 biocompatible polymer Polymers 0.000 claims 3
- 210000000988 bone and bone Anatomy 0.000 claims 3
- 239000004053 dental implant Substances 0.000 claims 3
- 210000003709 heart valve Anatomy 0.000 claims 3
- 229960000235 temsirolimus Drugs 0.000 claims 3
- QFJCIRLUMZQUOT-UHFFFAOYSA-N temsirolimus Natural products C1CC(O)C(OC)CC1CC(C)C1OC(=O)C2CCCCN2C(=O)C(=O)C(O)(O2)C(C)CCC2CC(OC)C(C)=CC=CC=CC(C)CC(C)C(=O)C(OC)C(O)C(C)=CC(C)C(=O)C1 QFJCIRLUMZQUOT-UHFFFAOYSA-N 0.000 claims 3
- CGTADGCBEXYWNE-GTTQIJKGSA-N zotarolimus Chemical compound N1([C@H]2CC[C@@H](C[C@@H](C)[C@H]3OC(=O)[C@@H]4CCCCN4C(=O)C(=O)[C@@]4(O)[C@H](C)CC[C@H](O4)C[C@@H](\C(C)=C\C=C\C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C3)OC)C[C@H]2OC)C=NN=N1 CGTADGCBEXYWNE-GTTQIJKGSA-N 0.000 claims 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims 2
- 229940122361 Bisphosphonate Drugs 0.000 claims 2
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 claims 2
- 102000009024 Epidermal Growth Factor Human genes 0.000 claims 2
- 101800003838 Epidermal growth factor Proteins 0.000 claims 2
- 239000004593 Epoxy Substances 0.000 claims 2
- YACHGFWEQXFSBS-UHFFFAOYSA-N Leptomycin B Natural products OC(=O)C=C(C)CC(C)C(O)C(C)C(=O)C(C)C=C(C)C=CCC(C)C=C(CC)C=CC1OC(=O)C=CC1C YACHGFWEQXFSBS-UHFFFAOYSA-N 0.000 claims 2
- 108010006519 Molecular Chaperones Proteins 0.000 claims 2
- 102000000536 PPAR gamma Human genes 0.000 claims 2
- 108010016731 PPAR gamma Proteins 0.000 claims 2
- 239000004952 Polyamide Substances 0.000 claims 2
- 239000002202 Polyethylene glycol Substances 0.000 claims 2
- 239000004721 Polyphenylene oxide Substances 0.000 claims 2
- 239000004793 Polystyrene Substances 0.000 claims 2
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 claims 2
- 229940079156 Proteasome inhibitor Drugs 0.000 claims 2
- SSNQAUBBJYCSMY-UHFFFAOYSA-N aigialomycin A Natural products C12OC2CC(O)C(O)C(=O)C=CCC(C)OC(=O)C=2C1=CC(OC)=CC=2O SSNQAUBBJYCSMY-UHFFFAOYSA-N 0.000 claims 2
- 239000003242 anti bacterial agent Substances 0.000 claims 2
- 229940124599 anti-inflammatory drug Drugs 0.000 claims 2
- 230000001028 anti-proliverative effect Effects 0.000 claims 2
- 230000000692 anti-sense effect Effects 0.000 claims 2
- 229940088710 antibiotic agent Drugs 0.000 claims 2
- 150000004663 bisphosphonates Chemical class 0.000 claims 2
- 229920002678 cellulose Polymers 0.000 claims 2
- 239000001913 cellulose Substances 0.000 claims 2
- 238000003486 chemical etching Methods 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 229940116977 epidermal growth factor Drugs 0.000 claims 2
- 239000000262 estrogen Substances 0.000 claims 2
- 229940011871 estrogen Drugs 0.000 claims 2
- SSNQAUBBJYCSMY-KNTMUCJRSA-N hypothemycin Chemical compound O([C@@H](C)C\C=C/C(=O)[C@@H](O)[C@@H](O)C[C@H]1O[C@@H]11)C(=O)C=2C1=CC(OC)=CC=2O SSNQAUBBJYCSMY-KNTMUCJRSA-N 0.000 claims 2
- 230000001788 irregular Effects 0.000 claims 2
- YACHGFWEQXFSBS-XYERBDPFSA-N leptomycin B Chemical compound OC(=O)/C=C(C)/C[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@H](C)/C=C(\C)/C=C/C[C@@H](C)/C=C(/CC)\C=C\[C@@H]1OC(=O)C=C[C@@H]1C YACHGFWEQXFSBS-XYERBDPFSA-N 0.000 claims 2
- 239000003446 ligand Substances 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 229960005419 nitrogen Drugs 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- 239000002773 nucleotide Substances 0.000 claims 2
- 125000003729 nucleotide group Chemical group 0.000 claims 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims 2
- 239000003614 peroxisome proliferator Substances 0.000 claims 2
- 238000001259 photo etching Methods 0.000 claims 2
- 238000001020 plasma etching Methods 0.000 claims 2
- 229920001432 poly(L-lactide) Polymers 0.000 claims 2
- 229920002647 polyamide Polymers 0.000 claims 2
- 229920001610 polycaprolactone Polymers 0.000 claims 2
- 239000004632 polycaprolactone Substances 0.000 claims 2
- 229920000728 polyester Polymers 0.000 claims 2
- 229920000570 polyether Polymers 0.000 claims 2
- 229920001223 polyethylene glycol Polymers 0.000 claims 2
- 229920000642 polymer Polymers 0.000 claims 2
- 229920001296 polysiloxane Polymers 0.000 claims 2
- 229920002223 polystyrene Polymers 0.000 claims 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims 2
- 239000004810 polytetrafluoroethylene Substances 0.000 claims 2
- 229920002635 polyurethane Polymers 0.000 claims 2
- 239000004814 polyurethane Substances 0.000 claims 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 2
- 239000003207 proteasome inhibitor Substances 0.000 claims 2
- 102000005962 receptors Human genes 0.000 claims 2
- 108020003175 receptors Proteins 0.000 claims 2
- 239000005483 tyrosine kinase inhibitor Substances 0.000 claims 2
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims 2
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/668,708 US7753962B2 (en) | 2007-01-30 | 2007-01-30 | Textured medical devices |
| PCT/US2008/051128 WO2008094760A2 (en) | 2007-01-30 | 2008-01-16 | Textured medical devices |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010516432A JP2010516432A (ja) | 2010-05-20 |
| JP2010516432A5 true JP2010516432A5 (enExample) | 2011-03-10 |
Family
ID=39560935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009548356A Pending JP2010516432A (ja) | 2007-01-30 | 2008-01-16 | 凹凸のある医療機器 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US7753962B2 (enExample) |
| EP (1) | EP2114482A2 (enExample) |
| JP (1) | JP2010516432A (enExample) |
| WO (1) | WO2008094760A2 (enExample) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8632583B2 (en) | 2011-05-09 | 2014-01-21 | Palmaz Scientific, Inc. | Implantable medical device having enhanced endothelial migration features and methods of making the same |
| US8268340B2 (en) * | 2002-09-26 | 2012-09-18 | Advanced Bio Prosthetic Surfaces, Ltd. | Implantable materials having engineered surfaces and method of making same |
| CA2499976C (en) | 2002-09-26 | 2013-06-11 | Advanced Bio Prosthetic Surfaces, Ltd. | Implantable materials having engineered surfaces and method of making same |
| US8679517B2 (en) | 2002-09-26 | 2014-03-25 | Palmaz Scientific, Inc. | Implantable materials having engineered surfaces made by vacuum deposition and method of making same |
| US8017074B2 (en) | 2004-01-07 | 2011-09-13 | Noxilizer, Inc. | Sterilization system and device |
| CA2552735C (en) * | 2004-01-07 | 2012-09-11 | Noxilizer, Inc. | Sterilization system and device |
| US8088163B1 (en) | 2008-02-06 | 2012-01-03 | Kleiner Jeffrey B | Tools and methods for spinal fusion |
| US20210378834A1 (en) | 2008-05-22 | 2021-12-09 | Spinal Surgical Strategies, Inc., A Nevada Corporation D/B/A Kleiner Device Labs | Spinal fusion cage system with inserter |
| US20090326646A1 (en) * | 2008-06-27 | 2009-12-31 | Medtronic Vascular, Inc. | Methods and Apparatus for Multiple Cured Formulation Coated Stents |
| USD853560S1 (en) | 2008-10-09 | 2019-07-09 | Nuvasive, Inc. | Spinal implant insertion device |
| US9168159B2 (en) * | 2008-11-06 | 2015-10-27 | Biosensors International Group, Ltd. | Surface textured implants |
| US9717403B2 (en) | 2008-12-05 | 2017-08-01 | Jeffrey B. Kleiner | Method and apparatus for performing retro peritoneal dissection |
| US8864654B2 (en) | 2010-04-20 | 2014-10-21 | Jeffrey B. Kleiner | Method and apparatus for performing retro peritoneal dissection |
| US8366748B2 (en) | 2008-12-05 | 2013-02-05 | Kleiner Jeffrey | Apparatus and method of spinal implant and fusion |
| US9247943B1 (en) | 2009-02-06 | 2016-02-02 | Kleiner Intellectual Property, Llc | Devices and methods for preparing an intervertebral workspace |
| USD656610S1 (en) | 2009-02-06 | 2012-03-27 | Kleiner Jeffrey B | Spinal distraction instrument |
| US8425837B2 (en) | 2009-02-23 | 2013-04-23 | Noxilizer, Inc. | Device and method for gas sterilization |
| US9186193B2 (en) | 2009-09-18 | 2015-11-17 | Spinal Surgical Strategies, Llc | Fusion cage with combined biological delivery system |
| US8685031B2 (en) | 2009-09-18 | 2014-04-01 | Spinal Surgical Strategies, Llc | Bone graft delivery system |
| US10245159B1 (en) | 2009-09-18 | 2019-04-02 | Spinal Surgical Strategies, Llc | Bone graft delivery system and method for using same |
| US9060877B2 (en) | 2009-09-18 | 2015-06-23 | Spinal Surgical Strategies, Llc | Fusion cage with combined biological delivery system |
| USD750249S1 (en) | 2014-10-20 | 2016-02-23 | Spinal Surgical Strategies, Llc | Expandable fusion cage |
| US9629729B2 (en) | 2009-09-18 | 2017-04-25 | Spinal Surgical Strategies, Llc | Biological delivery system with adaptable fusion cage interface |
| USD723682S1 (en) | 2013-05-03 | 2015-03-03 | Spinal Surgical Strategies, Llc | Bone graft delivery tool |
| US8906028B2 (en) | 2009-09-18 | 2014-12-09 | Spinal Surgical Strategies, Llc | Bone graft delivery device and method of using the same |
| US10973656B2 (en) | 2009-09-18 | 2021-04-13 | Spinal Surgical Strategies, Inc. | Bone graft delivery system and method for using same |
| US20170238984A1 (en) | 2009-09-18 | 2017-08-24 | Spinal Surgical Strategies, Llc | Bone graft delivery device with positioning handle |
| US9173694B2 (en) | 2009-09-18 | 2015-11-03 | Spinal Surgical Strategies, Llc | Fusion cage with combined biological delivery system |
| DE102009049175A1 (de) * | 2009-10-13 | 2011-04-21 | Bjarne Geiges | Vorrichtung zum Verabreichen von Arzneimitteln und zum Beeinflussen von Arzneimittelwirkungen |
| US20130045277A1 (en) * | 2010-02-03 | 2013-02-21 | Tetsushi Taguchi | Biocompatible device |
| US8728563B2 (en) | 2011-05-03 | 2014-05-20 | Palmaz Scientific, Inc. | Endoluminal implantable surfaces, stents, and grafts and method of making same |
| US12226301B2 (en) | 2011-05-09 | 2025-02-18 | Vactronix Scientific, Llc | Method of making topographical features and patterns on a surface of a medical device |
| US9050394B2 (en) | 2011-05-09 | 2015-06-09 | Palmaz Scientific, Inc. | Method for making topographical features on a surface of a medical device |
| US11045297B2 (en) | 2012-10-18 | 2021-06-29 | Vactronix Scientific Llc | Topographical features and patterns on a surface of a medical device and methods of making the same |
| WO2013059645A1 (en) | 2011-10-21 | 2013-04-25 | Abbott Cardiovascular Systems Inc. | Surface modification of medical devices to enhance endothelial adhesion and coverage |
| EP2967823A4 (en) * | 2013-03-13 | 2016-11-16 | Palmaz Scient Inc | TOPOGRAPHIC FUNCTIONS AND PATTERNS ON THE SURFACE OF A MEDICAL DEVICE AND METHOD OF MANUFACTURING THEREOF |
| EP2789312A1 (en) * | 2013-04-09 | 2014-10-15 | Epygon Sasu | Expandable stent-valve and method for manufacturing a stent |
| CN104587534A (zh) * | 2013-10-31 | 2015-05-06 | 先健科技(深圳)有限公司 | 可吸收铁基合金支架 |
| USD797290S1 (en) | 2015-10-19 | 2017-09-12 | Spinal Surgical Strategies, Llc | Bone graft delivery tool |
| US10610621B2 (en) * | 2017-03-21 | 2020-04-07 | International Business Machines Corporation | Antibacterial medical implant surface |
| MX2023002142A (es) * | 2020-08-25 | 2023-03-17 | Canary Medical Switzerland Ag | Dispositivo de oclusion con funcionalidad de deteccion. |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4882245A (en) | 1985-10-28 | 1989-11-21 | International Business Machines Corporation | Photoresist composition and printed circuit boards and packages made therewith |
| US4795472A (en) * | 1987-01-28 | 1989-01-03 | Zimmer, Inc. | Prosthesis with enhanced surface finish |
| US4955907A (en) * | 1987-12-22 | 1990-09-11 | Ledergerber Walter J | Implantable prosthetic device |
| US6419491B1 (en) * | 1993-11-02 | 2002-07-16 | Bio-Lok International, Inc. | Dental implant system with repeating microgeometric surface patterns |
| US20010039454A1 (en) * | 1993-11-02 | 2001-11-08 | John Ricci | Orthopedic implants having ordered microgeometric surface patterns |
| US5362718A (en) | 1994-04-18 | 1994-11-08 | American Home Products Corporation | Rapamycin hydroxyesters |
| US5947893A (en) * | 1994-04-27 | 1999-09-07 | Board Of Regents, The University Of Texas System | Method of making a porous prothesis with biodegradable coatings |
| US6676704B1 (en) * | 1994-08-12 | 2004-01-13 | Diamicron, Inc. | Prosthetic joint component having at least one sintered polycrystalline diamond compact articulation surface and substrate surface topographical features in said polycrystalline diamond compact |
| US6015815A (en) | 1997-09-26 | 2000-01-18 | Abbott Laboratories | Tetrazole-containing rapamycin analogs with shortened half-lives |
| US6258121B1 (en) * | 1999-07-02 | 2001-07-10 | Scimed Life Systems, Inc. | Stent coating |
| US20050238686A1 (en) * | 1999-12-23 | 2005-10-27 | Advanced Cardiovascular Systems, Inc. | Coating for implantable devices and a method of forming the same |
| US7083642B2 (en) * | 2000-12-22 | 2006-08-01 | Avantec Vascular Corporation | Delivery of therapeutic capable agents |
| CN100502808C (zh) * | 2001-05-25 | 2009-06-24 | 肯弗默斯股份有限公司 | 用于关节表面再造的组合物 |
| US6979346B1 (en) | 2001-08-08 | 2005-12-27 | Advanced Cardiovascular Systems, Inc. | System and method for improved stent retention |
| DE10320262A1 (de) | 2003-05-07 | 2004-12-02 | Meko Laserstrahl-Materialbearbeitungen E.K. | Verfahren zur Herstellung eines medizinischen Implantates sowie ein auf diese Weise hergestelltes Implantat |
| US7041127B2 (en) * | 2003-05-28 | 2006-05-09 | Ledergerber Walter J | Textured and drug eluting coronary artery stent |
| US20060083772A1 (en) | 2004-04-06 | 2006-04-20 | Dewitt David M | Coating compositions for bioactive agents |
| WO2007095549A2 (en) | 2006-02-13 | 2007-08-23 | Medtronic, Inc. | Medical devices having textured surfaces |
| US8062378B2 (en) * | 2007-03-26 | 2011-11-22 | Mx Orthopedics Corp. | Proximal self-locking long bone prosthesis |
| US20090076591A1 (en) * | 2007-09-19 | 2009-03-19 | Boston Scientific Scimed, Inc. | Stent Design Allowing Extended Release of Drug and/or Enhanced Adhesion of Polymer to OD Surface |
| JP5581311B2 (ja) * | 2008-04-22 | 2014-08-27 | ボストン サイエンティフィック サイムド，インコーポレイテッド | 無機材料のコーティングを有する医療デバイス及びその製造方法 |
| US20100106234A1 (en) * | 2008-10-23 | 2010-04-29 | Medtronic Vascular, Inc. | Medical Devices With Extended Drug Diffusion Pathway |
-
2007
- 2007-01-30 US US11/668,708 patent/US7753962B2/en not_active Expired - Fee Related
-
2008
- 2008-01-16 EP EP08727723A patent/EP2114482A2/en not_active Ceased
- 2008-01-16 JP JP2009548356A patent/JP2010516432A/ja active Pending
- 2008-01-16 WO PCT/US2008/051128 patent/WO2008094760A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010516432A5 (enExample) | ||
| US7753962B2 (en) | Textured medical devices | |
| US10029034B2 (en) | Drug-eluting articles with improved drug release profiles | |
| US8221783B2 (en) | Medical devices with triggerable bioadhesive material | |
| US8257729B2 (en) | Implants with membrane diffusion-controlled release of active ingredient | |
| ES2479193T3 (es) | Revestimientos incluyendo acetato de dexametasona y fármacos olimus | |
| EP1957007A1 (en) | Coated and imprinted medical devices and methods of making the same | |
| EP2012844A2 (en) | Durable biocompatible controlled drug release polymeric coatings for medical devices | |
| US20090304767A1 (en) | Bio-Degradable Block Co-Polymers for Controlled Release | |
| CN101765436A (zh) | 包括具有药物溶解度梯度的聚合物药物递送系统的医疗器械 | |
| WO2009076592A2 (en) | Medical devices having porous component for controlled diffusion | |
| US9737641B2 (en) | Method of fabricating an implantable medical device comprising a rapamycin derivative | |
| JP2011514428A (ja) | 一酸化窒素放出ポリマー組成物 | |
| US20090104244A1 (en) | Therapeutic agent-eluting medical devices having textured polymeric surfaces | |
| WO2015119976A1 (en) | Modified pla polymer and method of making and using | |
| US9056153B2 (en) | Biocompatible polymers for coating or fabricating implantable medical devices | |
| EP2911712A1 (en) | Stent having a tacky silicone coating to prevent stent migration | |
| US20140102049A1 (en) | Method Of Fabrication Of Implantable Medical Device Comprising Macrocyclic Triene Active Agent And Antioxidant |